Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Technology Industry News InfoBeans Technologies FY25 profit rises 69% on margin expansion and global demand InfoBeans FY25 PAT jumps 69% on strong EBITDA margins and global traction. See stock sentiment, FII/DII flows, and expert outlook for FY26 growth trends. byPallavi MadhirajuMay 4, 2025